Jun 2, 2021
Renovacor Announces the Appointment of Marc Semigran, M.D., as Chief Medical Officer

PHILADELPHIA and BOSTON, June 02, 2021 (GLOBE NEWSWIRE) -- Renovacor, Inc. (“Renovacor”), an early‑stage biotechnology...

Read More
May 20, 2021
HAYA Therapeutics Completes CHF 18 Million Seed Financing To Advance Anti-fibrotic Therapies Targeting Long Non-coding RNAs

Lausanne, Switzerland, 20 May 2021 -- HAYA Therapeutics, SA, a company developing precision medicines that...

Read More
Mar 23, 2021
Renovacor, Inc. to Merge with Chardan Healthcare Acquisition 2 Corp.

PHILADELPHIA and NEW YORK, March 23, 2021 /PRNewswire/ -- Renovacor, Inc. ("Renovacor" or the "Company"), an...

Read More
Dec 7, 2020
Basking Biosciences, Inc. Completes $5.4M Seed Financing

December 07, 2020 08:30 AM Eastern Standard Time COLUMBUS, Ohio--(BUSINESS WIRE)--Basking Biosciences, Inc. (Basking), a...

Read More
Nov 30, 2020
Vectorious’ in-heart microcomputer is granted FDA breakthrough designation

November 30, 2020. Vectorious Medical Technologies today announced that the FDA has granted breakthrough device...

Read More
Oct 20, 2020
FineHeart Achieves Milestone for its Miniaturized Heart Pump Technology with Successful Completion of 30-Day Preclinical Study

Bordeaux, France - October 20, 2020. – FineHeart, SA, a preclinical-stage medical device company developing...

Read More